Dose-dependent effects of adjunctive treatment with aripiprazole on hyperprolactinemia induced by risperidone in female patients with schizophrenia.
about
Adjunctive aripiprazole in risperidone-induced hyperprolactinaemia: double-blind, randomised, placebo-controlled trial.The effects of novel and newly approved antipsychotics on serum prolactin levels: a comprehensive review.The effects of additional treatment with terguride, a partial dopamine agonist, on hyperprolactinemia induced by antipsychotics in schizophrenia patients: a preliminary studyTreating symptomatic hyperprolactinemia in women with schizophrenia: presentation of the ongoing DAAMSEL clinical trial (Dopamine partial Agonist, Aripiprazole, for the Management of Symptomatic ELevated prolactin).Hyperprolactinemia during antipsychotics treatment increases the level of coagulation markers.Adjunctive treatment with aripiprazole for risperidone-induced hyperprolactinemiaThe facts about sexual (Dys)function in schizophrenia: an overview of clinically relevant findings.Safety and tolerability of antipsychotic polypharmacy.Management of a microprolactinoma with aripiprazole in a woman with cabergoline-induced mania.Prolactin serum concentrations during aripiprazole treatment in youth.Paliperidone and aripiprazole differentially affect the strength of calcium-secretion coupling in female pituitary lactotrophs.Aripiprazole-induced Hyperprolactinemia in a Young Female with Delusional DisorderEffect of aripiprazole on cognitive function and hyperprolactinemia in patients with schizophrenia treated with risperidoneAntipsychotic Induced Symptomatic Hyperprolactinemia: Are Dopamine Agonists Safe?Treatment of hyperprolactinemia and gynecomastia with adjunctive aripiprazole in 2 men receiving long-acting injectable antipsychotics.Treating symptomatic hyperprolactinemia secondary to a long-acting injectable atypical antipsychotic in a patient with bipolar disorder due to an anoxic brain injury.Antipsychotic-induced hyperprolactinaemia.Strategies for the treatment of antipsychotic-induced sexual dysfunction and/or hyperprolactinemia among patients of the schizophrenia spectrum: a review.The search for new biomarkers for cognition in schizophrenia.Frequency of hyperprolactinemia and its associations with demographic and clinical characteristics and antipsychotic medications in psychiatric inpatients in China.A Comment on "Add-on Aripiprazole for Atypical Antipsychotic-induced, Clinically Significant Hyperprolactinemia".Amenorrhea as a Side Effect of Low Dose Aripiprazole: An Adolescent Case
P2860
Q30490025-46073D7D-B1D0-42C2-8702-3DC142F18AC5Q33619940-3270BF61-474A-4EDD-97CC-AA0D3E2D8A12Q34110039-FDB0FDD1-2EFC-4A63-8A7F-4DA2309C4BBBQ34966395-1E99BDE8-5089-4934-A1A9-9BB4CF95DC18Q35142660-15D60297-E375-456F-B462-8903D3A1E568Q35167958-3F2EC380-9D54-468D-9C88-9C5261375EE2Q35369968-32D87ECA-936A-43A5-A2B8-4129814673A4Q36062421-C48299E4-9669-4F24-B8E0-80A914C7565CQ36294140-E36CB99B-EFA2-4809-AB99-EC55A9DEF7FAQ36853126-ADA5E4EA-3BFD-4F30-8999-7207604F5728Q36972523-9ECD5A4E-128F-4603-BD95-F1E2FB5754BDQ36997248-740FB55D-E142-4B94-9984-3A009339BAB0Q37155297-1D2237F8-58CF-472B-8F32-73EF62489B5AQ37299987-C45AAE3A-23E4-492B-8A66-F1EEA0581C4AQ37407131-7FEB2A14-4E2A-4A9C-8D19-317F8349500BQ37533845-1577297D-81E3-4CB9-BF87-8C97009F213EQ37895702-6C265246-1BD9-4B06-AC30-DB571E375F40Q38005470-845991F0-1C01-456C-A651-EDA96D5AF81EQ43376611-581EABC7-8B19-48E7-AE50-F9EDA7205332Q48397820-4F4B5150-61A1-4471-AAB2-729671128F44Q55009521-87C00F8B-9619-43B8-B060-BA937B702E81Q58781414-2976FC78-B6F1-4C04-A5EF-0000269A91EF
P2860
Dose-dependent effects of adjunctive treatment with aripiprazole on hyperprolactinemia induced by risperidone in female patients with schizophrenia.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Dose-dependent effects of adju ...... e patients with schizophrenia.
@en
Dose-dependent effects of adju ...... e patients with schizophrenia.
@nl
type
label
Dose-dependent effects of adju ...... e patients with schizophrenia.
@en
Dose-dependent effects of adju ...... e patients with schizophrenia.
@nl
prefLabel
Dose-dependent effects of adju ...... e patients with schizophrenia.
@en
Dose-dependent effects of adju ...... e patients with schizophrenia.
@nl
P2093
P1476
Dose-dependent effects of adju ...... e patients with schizophrenia.
@en
P2093
Akira Fujii
Hanako Furukori
Norio Sugawara
Sunao Kaneko
P304
P356
10.1097/JCP.0B013E3181EE832D
P407
P577
2010-10-01T00:00:00Z